High expression of <scp>CD</scp>44v9 and <scp>xCT</scp> in chemoresistant hepatocellular carcinoma: Potential targets by sulfasalazineFumitaka Wada, Takuji Torimura, Hironori Koga et al.|Cancer Science|2018Cited by 83
Weekends-Off Lenvatinib for Unresectable Hepatocellular Carcinoma Improves Therapeutic Response and Tolerability Toward Adverse EventsHideki Iwamoto, Takuji Torimura, Masahito Nakano et al.|Cancers|2020Cited by 68
Glycosylation of ascites-derived exosomal CD133: a potential prognostic biomarker in patients with advanced pancreatic cancerTakahiko Sakaue, Takuji Torimura, Hironori Koga et al.|Medical Molecular Morphology|2019Cited by 63
Pancreatic Neuroendocrine Tumors and EMT Behavior Are Driven by the CSC Marker DCLK1Yu Ikezono, Takuji Torimura, Hironori Koga et al.|Molecular Cancer Research|2017Cited by 39
Promotion of liver regeneration and anti‑fibrotic effects of the TGF‑β receptor kinase inhibitor galunisertib in CCl4‑treated miceAtsutaka Masuda, Takuji Torimura, Tõru Nakamura et al.|International Journal of Molecular Medicine|2020Cited by 34